News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pricing Of Offering Of Inveresk Research (Incorporating CTBR) (IRGI) Common Stock



10/19/2005 5:10:39 PM

CARY, N.C., April 1 /PRNewswire-FirstCall/ -- Inveresk Research Group, Inc. announced today that its principal stockholder yesterday agreed to sell 5,000,000 shares of Inveresk Research common stock at an initial price to the public of $26.75 per share. The offering is comprised entirely of shares being offered by such principal stockholder. The underwriter for the offering is Goldman, Sachs & Co.

This press release does not constitute an offer of the securities described herein. A registration statement relating to the securities has been previously declared effective by the Securities and Exchange Commission. The offering is being made solely by means of a prospectus supplement and the accompanying prospectus, copies of which may be obtained from Goldman Sachs & Co., 85 Broad Street, New York, NY 10004, Attention: Prospectus Department.

Inveresk is a leading provider of drug development services to companies in the pharmaceutical and biotechnology industries. The company is based in Cary, North Carolina with facilities in Edinburgh, Scotland and Montreal, Canada.

Inveresk Research Group, Inc.

CONTACT: Matt Dallas of Financial Dynamics, +1-212-850-5627,mdallas@fd-us.com, for Inveresk Research Group, Inc.


Read at Reuters
Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES